A Game-Changer For Pfizer Inc. (PFE)

3 Drug Launches You Need to Know in 2013: Pfizer, NPS Pharma, Ariad PharmaThe wealth-building power of compound interest will never cease to amaze me. It’s a story of patience and attention to detail, where small, short-term differences add up to massive divergence over decades. And in the end, the biggest winners don’t always deliver the fattest share-price returns.

Biopharma giant Pfizer Inc. (NYSE:PFE) just reported a disappointing first quarter. Pfizer Inc. (NYSE:PFE) share prices fell as much as 4.8% on a generally flat market day, making the stock the worst performer on the Dow Jones Industrial Average (Dow Jones Indices:.DJI) today — by a long shot. The company missed Wall Street’s revenue and earnings targets as key products started falling out of patent protection

But Pfizer Inc. (NYSE:PFE)’s stock still trades less than 6% below recently set all-time highs, and management boosted dividend payments by 9% last quarter. The shares offer a meaty 3.3% dividend yield, even at these skyrocketing prices. And that dividend muscle is what turns Pfizer Inc. (NYSE:PFE)’s proven cash machine into a market-crushing investment vehicle.

PFE Dividend Chart

PFE Dividend data by YCharts.

Reinvesting Pfizer’s dividends is a winning strategy. That way, you put some serious distance between dividend-adjusted returns and the Dow’s gains. Pfizer even beats the total return of fellow Dow member Merck & Co., Inc. (NYSE:MRK).

And here’s why: Pfizer Inc. (NYSE:PFE) did slash dividend payouts in response to the 2008 and 2009 global economic crisis, but it has boosted its policy every year since then. Merck & Co., Inc. (NYSE:MRK) has provided just two dividend boosts in the last four years. All told, Pfizer’s payouts have jumped 50% since the post-crisis rock bottom, while Merck’s only gained 13%.

Not only that, but Pfizer Inc. (NYSE:PFE)’s dividends still have more room to grow than Merck & Co., Inc. (NYSE:MRK)’s. Both companies pocket a generous share of their free cash flows, but Pfizer uses a smaller portion of its cash for dividend payments. And unlike Merck’s, Pfizer’s cash funding never dried out, even at the height of that old crisis.

PFE Cash Div. Payout Ratio TTM Chart

PFE Cash Div. Payout Ratio TTM data by YCharts.

These are the details that make income investors sleep soundly at night with some Pfizer Inc. (NYSE:PFE) stock under their pillows. Don’t let one disappointing quarter scare you away from this hulking generator and sharer of cash.

The article How Dividends Change the Game for Owners of Pfizer Stock originally appeared on Fool.com and is written by Anders Bylund.

Fool contributor Anders Bylund holds no position in any company mentioned. Check out Anders’ bio and holdings or follow him on Twitter and Google+.The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!